A detailed history of Seeyond transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Seeyond holds 8,511 shares of VRTX stock, worth $4.28 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
8,511
Previous 10,907 21.97%
Holding current value
$4.28 Million
Previous $3.16 Million 22.2%
% of portfolio
0.24%
Previous 0.38%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $684,680 - $770,266
-2,396 Reduced 21.97%
8,511 $2.46 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $319,559 - $356,553
1,167 Added 11.98%
10,907 $3.16 Million
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $705,584 - $878,527
-3,003 Reduced 23.57%
9,740 $2.74 Million
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $84,139 - $99,168
-380 Reduced 2.9%
12,743 $3.33 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $646,971 - $816,709
3,655 Added 38.6%
13,123 $2.88 Million
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $441,503 - $494,077
-2,434 Reduced 20.45%
9,468 $1.72 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $16,124 - $19,014
-86 Reduced 0.72%
11,902 $2.4 Million
Q1 2021

May 14, 2021

BUY
$207.02 - $241.31 $16,147 - $18,822
78 Added 0.65%
11,988 $2.58 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $233,714 - $311,705
1,129 Added 10.47%
11,910 $2.81 Million
Q3 2020

Nov 12, 2020

BUY
$255.65 - $303.1 $373,760 - $443,132
1,462 Added 15.69%
10,781 $2.93 Million
Q2 2020

Aug 13, 2020

SELL
$225.48 - $295.8 $242,391 - $317,985
-1,075 Reduced 10.34%
9,319 $2.71 Million
Q1 2020

May 14, 2020

BUY
$199.77 - $247.81 $196,174 - $243,349
982 Added 10.43%
10,394 $2.47 Million
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $55,681 - $74,785
-334 Reduced 3.43%
9,412 $2.06 Million
Q3 2019

Nov 13, 2019

BUY
$166.23 - $187.09 $765,821 - $861,923
4,607 Added 89.65%
9,746 $1.65 Million
Q2 2019

Aug 13, 2019

BUY
$164.61 - $190.37 $102,387 - $118,410
622 Added 13.77%
5,139 $942,000
Q4 2018

Feb 14, 2019

BUY
$151.91 - $192.21 $686,177 - $868,212
4,517 New
4,517 $749,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Seeyond Portfolio

Follow Seeyond and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.